Ignite Creation Date:
2025-12-25 @ 5:08 AM
Ignite Modification Date:
2026-03-02 @ 3:43 PM
Study NCT ID:
NCT02500927
Status:
TERMINATED
Last Update Posted:
2024-11-20
First Post:
2015-06-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of ASP8273 in Epidermal Growth Factor Receptor (EGFR) Tyrosine Kinase Inhibitor-Naïve Patients With Non-Small Cell Lung Cancer Harboring EGFR Mutations
Sponsor:
Astellas Pharma Inc
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-06-25
Start Date Type:
ACTUAL
Primary Completion Date:
2017-06-09
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-09
Completion Date Type:
ACTUAL
First Submit Date:
2015-06-25
First Submit QC Date:
None
Study First Post Date:
2015-07-17
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-11-18
Last Update Post Date:
2024-11-20
Last Update Post Date Type:
ACTUAL